Magbanua MJM, Brown Swigart L, Ahmed Z, Sayaman RW, et al. Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy. Cancer Cell 2023 May 3:S1535-6108(23)00134-4. doi: 10.1016/j.ccell.2023.
PMID: 37146605